1. Home
  2. ZLAB vs SBSW Comparison

ZLAB vs SBSW Comparison

Compare ZLAB & SBSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SBSW
  • Stock Information
  • Founded
  • ZLAB 2013
  • SBSW 2013
  • Country
  • ZLAB China
  • SBSW South Africa
  • Employees
  • ZLAB N/A
  • SBSW N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SBSW Precious Metals
  • Sector
  • ZLAB Health Care
  • SBSW Basic Materials
  • Exchange
  • ZLAB Nasdaq
  • SBSW Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • SBSW 3.2B
  • IPO Year
  • ZLAB 2017
  • SBSW N/A
  • Fundamental
  • Price
  • ZLAB $29.76
  • SBSW $6.32
  • Analyst Decision
  • ZLAB Buy
  • SBSW Hold
  • Analyst Count
  • ZLAB 4
  • SBSW 4
  • Target Price
  • ZLAB $47.37
  • SBSW $5.05
  • AVG Volume (30 Days)
  • ZLAB 944.8K
  • SBSW 10.6M
  • Earning Date
  • ZLAB 05-08-2025
  • SBSW 06-10-2025
  • Dividend Yield
  • ZLAB N/A
  • SBSW N/A
  • EPS Growth
  • ZLAB N/A
  • SBSW N/A
  • EPS
  • ZLAB N/A
  • SBSW N/A
  • Revenue
  • ZLAB $418,326,000.00
  • SBSW $5,938,469,800.00
  • Revenue This Year
  • ZLAB $44.07
  • SBSW $8.03
  • Revenue Next Year
  • ZLAB $49.13
  • SBSW $2.88
  • P/E Ratio
  • ZLAB N/A
  • SBSW N/A
  • Revenue Growth
  • ZLAB 43.72
  • SBSW N/A
  • 52 Week Low
  • ZLAB $16.01
  • SBSW $3.05
  • 52 Week High
  • ZLAB $39.77
  • SBSW $6.27
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 44.77
  • SBSW 74.07
  • Support Level
  • ZLAB $30.11
  • SBSW $6.00
  • Resistance Level
  • ZLAB $31.34
  • SBSW $6.27
  • Average True Range (ATR)
  • ZLAB 1.06
  • SBSW 0.20
  • MACD
  • ZLAB -0.02
  • SBSW 0.09
  • Stochastic Oscillator
  • ZLAB 36.04
  • SBSW 98.63

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SBSW D/B/A Sibanye-Stillwater Limited ADS

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

Share on Social Networks: